ValiRx accelerates the development of treatments in cancer and womens health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
| Registrars: |
Capita Registrars |
| CFO: |
Gerald Desler |
| Chief Executive Officer : |
Mark Eccleston |
| Non-Executive Chairman: |
Martin Gouldstone |
| Non-Executive Director: |
Cathy Tralau-Stewart |
| Address: |
20 Wenlock Road, London, England,United Kingdom |
| Phone: |
|
| Fax: |
|
| Website: |
http://www.valirx.com |
| Email: |
|